发明名称 INHIBITOR OF RIBONUCLEOTIDE REDUCTASE SUBUNIT 2 AND USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To provide inhibitors of R2, and their related methods and compositions that can achieve inhibition of R2 in target cells. <P>SOLUTION: The present application relates to the inhibitors of ribonucleotide reductase subunit 2 (R2), and methods and compositions related to the R2 inhibitors. In certain embodiments, the R2 inhibitors include nucleic acids, such as for example siRNAs. In particular, the target cells include those cells undergoing unwanted proliferation such as cancer or tumor cells, cells undergoing excessive growth and/or proliferation associated with certain diseases or conditions (e.g., T cells in autoimmune diseases or rejection of transplants), and pathogens. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012157368(A) 申请公布日期 2012.08.23
申请号 JP20120115832 申请日期 2012.05.21
申请人 CALANDO PHARMACEUTICALS INC 发明人 DAVIS MARK E;HEIDEL JEREMY D;ROOSI JOHN J
分类号 C12N15/113;A61K9/51;A61K31/7088;A61K45/00;A61K47/06;A61K47/26;A61K47/40;A61K47/42;A61K48/00;A61P31/04;A61P31/10;A61P31/12;A61P35/00;A61P43/00;C12N9/00 主分类号 C12N15/113
代理机构 代理人
主权项
地址